Andrey Emanuilov Manov, et al. “Comparison of the Effect on Hyperglycemia and the Adverse Effects Among Different GLP-1 Receptor Agonists Added to Basal Insulin and Between GLP-1 Receptor Agonists and Basal Insulin Versus Basal-Plus or Basal-Bolus Insulin in Type 2 Diabetes: A Meta-Analysis”. New Frontiers in Medicine and Medical Research Vol. 10, Aug. 2021, pp. 147-63, doi:10.9734/bpi/nfmmr/v10/4105F.